Rare diseases
Investigational molecules
Locations
7 Kunlunshan Road, Economic and Technological Development Zone, 222047
Research activity includes treatment strategies for metastatic hormone-sensitive prostate cancer with high tumor load and metastatic castration-resistant prostate cancer, with attention to disease control and progression outcomes in advanced prostate malignancy.
The sponsor’s oncology portfolio reflects a strong focus on advanced prostate cancer settings, including both hormone-sensitive and resistant disease states.
Jiangsu Hengrui Pharmaceuticals Co. Ltd. runs clinical trials in conditions such as Prostate cancer, Thrombocytopenia, Hormone-refractory prostate cancer, Prostate cancer metastatic, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaBulgaria
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
